| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 3,6 M € | +8.3% | 3,3 M € | -1.7% | 3,4 M € | +7.7% | 3,2 M € | -6.1% | 3,4 M € | +16.3% | 2,9 M € | +6.7% | 2,7 M € | -0.2% | 2,7 M € | +12.4% | 2,4 M € | +8.7% | 2,2 M € | +24.5% | 1,8 M € | +11.9% | 1,6 M € | -26.3% | 2,2 M € | +17.6% | 1,8 M € | -28.9% | 2,6 M € | |
| EBITDA | 3,6 M € | +8.3% | 3,3 M € | -1.5% | 3,4 M € | +7.8% | 3,1 M € | +609.1% | -618,2 k € | -121.4% | 2,9 M € | +6.7% | 2,7 M € | -0.2% | 2,7 M € | +12.4% | 2,4 M € | +8.7% | 2,2 M € | +24.6% | 1,8 M € | +11.9% | 1,6 M € | -26.3% | 2,2 M € | +17.6% | 1,8 M € | -28.9% | 2,6 M € | |
| Operating profit | 3,6 M € | +8.3% | 3,3 M € | -1.5% | 3,4 M € | +7.8% | 3,1 M € | +609.1% | -618,2 k € | -121.4% | 2,9 M € | +6.7% | 2,7 M € | -0.2% | 2,7 M € | +12.4% | 2,4 M € | +8.7% | 2,2 M € | +24.6% | 1,8 M € | +11.9% | 1,6 M € | -26.3% | 2,2 M € | +17.6% | 1,8 M € | -28.9% | 2,6 M € | |
| Profit/loss | 34,0 M € | +1084.6% | 2,9 M € | -6.3% | 3,1 M € | -74.7% | 12,1 M € | +1331.4% | -981,5 k € | -157.0% | 1,7 M € | +0.9% | 1,7 M € | -81.2% | 9,1 M € | +460.9% | 1,6 M € | -0.5% | 1,6 M € | +84.7% | 881,6 k € | -94.8% | 16,8 M € | +808.7% | 1,9 M € | +10.8% | 1,7 M € | -11.5% | 1,9 M € | |
| Equity | 16,8 M € | -71.0% | 57,8 M € | +5.2% | 55,0 M € | +5.9% | 51,9 M € | +36.7% | 38,0 M € | -2.5% | 38,9 M € | +4.6% | 37,2 M € | +4.8% | 35,5 M € | +34.4% | 26,4 M € | +6.5% | 24,8 M € | +7.0% | 23,2 M € | +4.0% | 22,3 M € | +306.9% | 5,5 M € | +51.1% | 3,6 M € | +85.6% | 2,0 M € | |
| Total assets | 47,2 M € | -19.1% | 58,3 M € | +5.7% | 55,1 M € | +5.8% | 52,1 M € | +36.5% | 38,2 M € | -2.0% | 39,0 M € | +4.8% | 37,2 M € | +4.8% | 35,5 M € | +16.3% | 30,6 M € | +0.9% | 30,3 M € | -3.7% | 31,5 M € | -11.1% | 35,4 M € | +530.4% | 5,6 M € | +54.7% | 3,6 M € | +83.3% | 2,0 M € | |
| Cash | 18,0 M € | -12.6% | 20,6 M € | -31.0% | 29,9 M € | +4.3% | 28,7 M € | +96.8% | 14,6 M € | +85.7% | 7,9 M € | +12.5% | 7,0 M € | +50.3% | 4,6 M € | +6100.2% | 74,9 k € | +162.9% | 28,5 k € | -94.9% | 563,8 k € | -25.5% | 757,0 k € | -80.1% | 3,8 M € | +27.5% | 3,0 M € | +88.1% | 1,6 M € | |
| Debts | 30,4 M € | +6208.2% | 482,1 k € | +153.6% | 190,1 k € | -23.9% | 249,7 k € | -2.5% | 256,2 k € | +350.2% | 56,9 k € | +27560.8% | 205,7 € | -45.2% | 375,1 € | -100.0% | 4,1 M € | -24.0% | 5,4 M € | -34.3% | 8,2 M € | -36.6% | 13,0 M € | +9585.6% | 134,0 k € | +7221.5% | 1,8 k € | -92.8% | 25,4 k € | |
Public limited company profitable but thinly capitalised. Cash position declining (-12.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (16,8 M €) relative to earnings. The abridged model hides revenue.
MAS A.G. is a Public limited company incorporated in 2009. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Sankt Vith.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette